{"id":"NCT03061214","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)","officialTitle":"Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes. A 30-week Randomised, Double-blind, Double-dummy, Active-controlled, Parallel-group, Multi-centre and Multi-national Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-08-28","primaryCompletion":"2019-03-14","completion":"2019-04-15","firstPosted":"2017-02-23","resultsPosted":"2020-04-09","lastUpdate":"2021-03-02"},"enrollment":868,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Semaglutide 0.5 mg","otherNames":[]},{"type":"DRUG","name":"Semaglutide 1.0 mg","otherNames":[]},{"type":"DRUG","name":"Sitagliptin placebo","otherNames":[]},{"type":"DRUG","name":"Sitagliptin","otherNames":[]},{"type":"DRUG","name":"Semaglutide placebo 0.5 mg","otherNames":[]},{"type":"DRUG","name":"Semaglutide placebo 1.0 mg","otherNames":[]}],"arms":[{"label":"Semaglutide 0.5 mg OW + sitagliptin placebo OD","type":"EXPERIMENTAL"},{"label":"Semaglutide 1 mg OW + sitagliptin placebo OD","type":"EXPERIMENTAL"},{"label":"Sitagliptin OD + semaglutide placebo 0.5 mg OW","type":"ACTIVE_COMPARATOR"},{"label":"Sitagliptin OD + semaglutide placebo 1 mg OW","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Africa, Asia, Europe and South America. The aim of the trial is to compare the effect of once-weekly dosing of two dose levels of semaglutide versus sitagliptin 100 mg once-daily on glycaemic control after 30 weeks of treatment. Subjects will remain on their stable pre-trial metformin.","primaryOutcome":{"measure":"Change in HbA1c","timeFrame":"Week 0, week 30","effectByArm":[{"arm":"Semaglutide 0.5 mg","deltaMin":-1.5,"sd":1.1},{"arm":"Semaglutide 1.0 mg","deltaMin":-1.8,"sd":0.9},{"arm":"Sitagliptin","deltaMin":-1,"sd":0.9}],"pValues":[{"comp":"OG001 vs OG002","p":"<.0001"},{"comp":"OG000 vs OG002","p":"<.0001"},{"comp":"OG001 vs OG002","p":"<.0001"},{"comp":"OG000 vs OG002","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":67,"countries":["Brazil","China","Hong Kong","South Africa","South Korea","Taiwan","Ukraine"]},"refs":{"pmids":["33074557","38236431"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":287},"commonTop":["Diarrhoea","Upper respiratory tract infection","Nausea","Lipase increased","Decreased appetite"]}}